[1]
M. A. Shah, S. Suleman, and A. H. Munir, “COMPARATIVE EFFICACY AND SAFETY PROFILE OF 5 MG ROSUVASTATIN VERSUS 10 MG ROSUVASTATIN IN PATIENTS WITH ISCHEMIC HEART DISEASE”, JMS, vol. 21, no. 1, pp. 35–39, Feb. 2013.